However, the role of GLP-1 RAs in psychiatric outcomes, particularly in depression or anxiety disorder, presents a mixed picture
They work through different mechanisms, theyre taken differently, and a clinician decides which one is appropriate for a given person
In high-income nations with established diabetes care systems, GLP-1 receptor agonists exhibit advantageous cost-effectiveness ratios when accounting for cardiovascular and renal protective benefits, with incremental cost-effectiveness ratios generally falling below $50,000 per quality-adjusted life year (QALY) for high-risk patients (Kong et al
Helps remove dark spots and excessive pigmentation, enhance the overall skin's appearance in both intimate areas and sensitive skin areas
In recent research, it has been found that MetS, which was defined by the World Health Organisation (WHO) in 1999, is strongly associated with an increased risk of coronary heart disease (CHD)